• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Pliant Therapeutics, Inc. - Common Stock (NQ:PLRX)

    1.195 +0.065 (+5.75%)
    Streaming Delayed Price Updated: 10:55 AM EST, Feb 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Pliant Therapeutics, Inc. - Common Stock

    News headline image
    Keep an eye on the top gainers and losers in Thursday's session. ↗
    Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Friday's After-Market Session ↗
     
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Friday's after-hours session. ↗
    Discover the top movers in Friday's after-hours session and stay informed about the post-market dynamics. 
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Pliant Therapeutics' Investigational Cancer Drug Shows Antitumor Activity Across Multiple Tumor Types ↗
    Pliant Therapeutics' PLN-101095 showed partial responses in ICI-refractory tumors, with a 50% ORR at the highest dose tested in its Phase 1 trial. 
    Via Benzinga
    News headline image
    What's going on in today's after hours session ↗
    After the closing bell on Monday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session. 
    Via Chartmill
    News headline image
    Pliant Therapeutics Drops IPF Drug Trial After Review, Analyst Flags Uncertain Future ↗
    Pliant Therapeutics ends its Phase 2b IPF trial for bexotegrast, prompting a Needham downgrade to Hold due to limited catalysts and pipeline challenges. 
    Via Benzinga
    News headline image
    This Teleflex Analyst Turns Bearish; Here Are Top 5 Downgrades For Tuesday ↗
     
    Via Benzinga
    News headline image
    Get insights into the top gainers and losers of Monday's after-hours session. ↗
    Discover the top movers in Monday's after-hours session and stay informed about the post-market dynamics. 
    Via Chartmill
    News headline image
    Here are the top movers in Monday's session. ↗
    Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    Pliant Therapeutics Stock Sinks, Discontinues Mid-Stage Study For Lung Disorder ↗
    Pliant Therapeutics discontinued its BEACON-IPF trial for bexotegrast due to safety concerns but observed early efficacy. The company plans further data analysis. 
    Via Benzinga
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    Which stocks are gapping on Monday? ↗
    Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps. 
    Via Chartmill
    News headline image
    Unusual volume stocks in Wednesday's session ↗
    On Wednesday, there are stocks with unusual volume. Let's take a look. 
    Via Chartmill
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Curious to know what's happening on the US markets one hour before the close of the markets on Monday? Join us as we explore the top gainers and losers in today's session. 
    Via Chartmill
    News headline image
    Crude Oil Rises Sharply; Manhattan Associates Shares Slide ↗
     
    Via Benzinga
    News headline image
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements. 
    Via Chartmill
    News headline image
    Nasdaq Surges 1%; ON Semiconductor Shares Plunge Following Earnings Miss ↗
     
    Via Benzinga
    News headline image
    This Illumina Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗
     
    Via Benzinga
    News headline image
    The market is filled with gapping stocks in Monday's session. ↗
    Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Monday. Let's explore the market movements and identify the stocks with significant gaps. 
    Via Chartmill
    News headline image
    Dow Gains 100 Points; McDonald's Shares Rise After Q4 Results ↗
     
    Via Benzinga
    Topics Stocks
    News headline image
    Monday's pre-market session: top gainers and losers ↗
    Wondering what's happening in Monday's pre-market session? Find an overview in this article. 
    Via Chartmill
    News headline image
    Pliant Therapeutics Pauses Lead Product Mid-Stage Trial In Patients With Stiff Lung Tissues ↗
    Pliant Therapeutics halted new enrollment in its BEACON-IPF trial after a safety board review. A separate study showed bexotegrast reduced lung collagen. 
    Via Benzinga
    News headline image
    Tesla, ON Semiconductor And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
     
    Via Benzinga
    News headline image
    Why RH Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    PLRX Stock Earnings: Pliant Therapeutics Misses EPS for Q2 2024 ↗
    PLRX stock results show that Pliant Therapeutics missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    7 Biotech Stocks to Buy on the Dip: June 2024 ↗
    With health being a top priority over wealth generation, these biotech stocks to buy on the dip enjoy a sound framework for speculation. 
    Via InvestorPlace
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.